Reference
NICE. Improved agreement means NICE now recommends lung cancer treatment Internet Document : 11 Sep 2020. Available from: URL: https://www.nice.org.uk/news/article/improved-agreement-means-nice-now-recommends-lung-cancer-treatment
Rights and permissions
About this article
Cite this article
NICE recommends osimertinib for advanced EGFR-positive NSCLC. PharmacoEcon Outcomes News 863, 35 (2020). https://doi.org/10.1007/s40274-020-7189-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7189-3